Skip to Main Content

Advertisement

Skip Nav Destination

MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with MTAP-Deleted Cancer

Cancer Discov (2023) 13 (11): 2412–2431.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Binbin Zhang
  • Youhong Guan
  • Daxiong Zeng
  • Ran Wang
Translational Research (2024)
  • J. Rodon
  • E. Rodriguez
  • M.L. Maitland
  • F.Y.-C. Tsai
  • M.A. Socinski
  • J.D. Berlin
  • J.S. Thomas
  • T. Al Baghdadi
  • I.-M. Wang
  • C. Guo
  • M. Golmakani
  • L.N. Clark
  • M. Gazdoiu
  • M. Li
  • A.W. Tolcher
ESMO Open (2024) 9 (4): 102961.
  • Tatjana Vlajnic
  • Obinna Chijioke
  • Luca Roma
  • Spasenija Savic Prince
  • Tobias Zellweger
  • Cyrill A. Rentsch
  • Lukas Bubendorf
Modern Pathology (2024) 37 (6): 100495.
  • Elisa Mariella
  • Gaia Grasso
  • Martina Miotto
  • Kristi Buzo
  • Nicole Megan Reilly
  • Pietro Andrei
  • Pietro Paolo Vitiello
  • Giovanni Crisafulli
  • Sabrina Arena
  • Giuseppe Rospo
  • Giorgio Corti
  • Annalisa Lorenzato
  • Carlotta Cancelliere
  • Ludovic Barault
  • Giulia Gionfriddo
  • Michael Linnebacher
  • Mariangela Russo
  • Federica Di Nicolantonio
  • Alberto Bardelli
Molecular Oncology (2024)
  • Karen M. Yun
  • Lyudmila Bazhenova
Cancers (2024) 16 (7): 1252.
  • Devendra Kumar
  • Stuti Jain
  • Don W. Coulter
  • Shantaram S. Joshi
  • Nagendra K. Chaturvedi
Cancers (2023) 15 (24): 5855.
Close Modal

or Create an Account

Close Modal
Close Modal